help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on May 3, 2007, doi:10.1164/rccm.200701-044OC

Am. J. Respir. Crit. Care Med., Volume 176, Number 3, August 2007, 277-284

A more recent version of this article appeared on August 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200701-044OCv1
176/3/277    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olson, A. L
Right arrow Articles by Brown, K. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olson, A. L
Right arrow Articles by Brown, K. K

Submitted on January 9, 2007
Accepted on May 3, 2007

Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003

Amy L Olson1*, Jeffrey J Swigris2, Dennis C Lezotte3, Jill M Norris3, Carla G Wilson4, and Kevin K Brown2

1 Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO, USA; Interstitial Lung Disease Division, National Jewish Medical and Research Center, Denver, CO, USA, 2 Interstitial Lung Disease Division, National Jewish Medical and Research Center, Denver, CO, USA; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, CO, USA, 3 Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO, USA, 4 Interstitial Lung Disease Division, National Jewish Medical and Research Center, Denver, CO, USA

* To whom correspondence should be addressed. E-mail: amy.olson{at}uchsc.edu.

Rationale: From the late 1970s to the early 1990s, studies found mortality rates for pulmonary fibrosis were increasing. Recent data for mortality from pulmonary fibrosis are unavailable. Objectives: We sought to determine mortality rates for pulmonary fibrosis in the United States from 1992 through 2003. Methods: Using data from the National Center for Health Statistics, we calculated age-adjusted mortality rates from the deaths of persons with pulmonary fibrosis and stratified the data to determine differences in mortality rates by age, gender, race/ethnicity, and geography of the decedent. We developed a multivariable model to predict future mortality rates, and we determined the underlying cause of death in patients with pulmonary fibrosis. Main Results: From 1992 to 2003, there were 28,176,224 deaths in the United States and 175,088 decedents with pulmonary fibrosis. The average age- and gender-adjusted mortality rate was 50.8 per 1,000,000 people. The age-adjusted mortality rate increased 28.4% in men (from 40.2 per 1,000,000 in 1992 to 61.9 per 1,000,000 in 2003) and 41.3% in women (from 39.0 per 1,000,000 in 1992 to 55.1 per 1,000,000 in 2003). While increases were significant in both men and women (p<0.0001), the rate of increase was higher in women (p<0.0001). The most common cause of death in patients with pulmonary fibrosis was the disease itself. Conclusion: From 1992 to 2003, mortality rates for pulmonary fibrosis significantly increased. Further investigation is needed to determine the etiology of these trends, which are predicted to continue to increase.


Key words: Pulmonary Fibrosis, Mortality Rate, Idiopathic Pulmonary Fibrosis, Epidemiology




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
D. S. Wilkes
Clinical Year in Review III: Idiopathic Pulmonary Fibrosis, Occupational Medicine, and Lung Transplantation
Proceedings of the ATS, September 15, 2008; 5(7): 751 - 754.
[Full Text] [PDF]


Home page
Eur Respir JHome page
C. E. Daniels, E. S. Yi, and J. H. Ryu
Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis
Eur. Respir. J., July 1, 2008; 32(1): 170 - 174.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. W. Voltz, J. W. Card, M. A. Carey, L. M. DeGraff, C. D. Ferguson, G. P. Flake, J. C. Bonner, K. S. Korach, and D. C. Zeldin
Male Sex Hormones Exacerbate Lung Function Impairment after Bleomycin-Induced Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 45 - 52.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
G. J. Laurent, R. J. McAnulty, M. Hill, and R. Chambers
Escape from the Matrix: Multiple Mechanisms for Fibroblast Activation in Pulmonary Fibrosis
Proceedings of the ATS, April 15, 2008; 5(3): 311 - 315.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. U. Wells and C. M. Hogaboam
Update in Diffuse Parenchymal Lung Disease 2007
Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 580 - 584.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2007 American Thoracic Society
  ATS State of the Art Course 2008